These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24825332)

  • 21. VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples.
    Arbyn M; Peeters E; Benoy I; Vanden Broeck D; Bogers J; De Sutter P; Donders G; Tjalma W; Weyers S; Cuschieri K; Poljak M; Bonde J; Cocuzza C; Zhao FH; Van Keer S; Vorsters A
    J Clin Virol; 2018 Oct; 107():52-56. PubMed ID: 30195193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collection.
    Belinson JL; Hu S; Niyazi M; Pretorius RG; Wang H; Wen C; Smith JS; Li J; Taddeo FJ; Burchette RJ; Qiao YL
    Int J Cancer; 2010 Sep; 127(5):1151-7. PubMed ID: 20039323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection.
    Nieves L; Enerson CL; Belinson S; Brainard J; Chiesa-Vottero A; Nagore N; Booth C; Pérez AG; Chávez-Avilés MN; Belinson J
    Int J Gynecol Cancer; 2013 Mar; 23(3):513-8. PubMed ID: 23334437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pap cytopathology and the presence of high-risk human papillomavirus in SurePath liquid preservative and Digene cervical sampler specimens.
    Kapala J; Jang D; Patel J; Biers K; Smieja M; Chernesky M
    J Virol Methods; 2007 Jun; 142(1-2):223-5. PubMed ID: 17320978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical performance of a human papillomavirus messenger RNA test (Aptima HPV Assay) on residual material from archived 3-year-old PreservCyt samples with low-grade squamous intraepithelial lesion.
    Waldstrøm M; Ornskov D
    Arch Pathol Lab Med; 2011 Aug; 135(8):1052-6. PubMed ID: 21809999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
    Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
    JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions.
    Dockter J; Schroder A; Hill C; Guzenski L; Monsonego J; Giachetti C
    J Clin Virol; 2009 Jul; 45 Suppl 1():S55-61. PubMed ID: 19651370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Self-collection of test material. Supplement to cervical cancer screening].
    Mangold BR
    Pathologe; 2013 Nov; 34(6):558-62. PubMed ID: 24051606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation of HPV-based Cervical Cancer Screening Combined with Self-sampling Using a Midwifery Network Across Rural Greece: The GRECOSELF Study.
    Agorastos T; Chatzistamatiou K; Tsertanidou A; Mouchtaropoulou E; Pasentsis K; Kitsou A; Moysiadis T; Moschaki V; Skenderi A; Katsiki E; Aggelidou S; Venizelos I; Ntoula M; Daponte A; Vanakara P; Garas A; Stefos T; Vrekoussis T; Lymberis V; Kontomanolis EN; Makrigiannakis A; Manidakis G; Deligeoroglou E; Panoskaltsis T; Decavalas GO; Michail G; Kalogiannidis I; Koukoulis G; Zempili P; Halatsi D; Truva T; Piha V; Agelena G; Chronopoulou A; Vaitsi V; Chatzaki E; Paschopoulos M; Adonakis G; Kaufmann AM; Hadzidimitriou A; Stamatopoulos K
    Cancer Prev Res (Phila); 2019 Oct; 12(10):701-710. PubMed ID: 31427275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-risk human papillomavirus messenger RNA testing in physician- and self-collected specimens for cervical lesion detection in high-risk women, Kenya.
    Ting J; Mugo N; Kwatampora J; Hill C; Chitwa M; Patel S; Gakure H; Kimani J; Schoenbach VJ; Poole C; Smith JS
    Sex Transm Dis; 2013 Jul; 40(7):584-9. PubMed ID: 23965776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-risk human papillomavirus detection in self-collected vaginal samples compared with healthcare worker collected cervical samples among women attending gynecology clinics at a tertiary hospital in Pretoria, South Africa.
    Tiiti TA; Mashishi TL; Nkwinika VV; Benoy I; Selabe SG; Bogers J; Lebelo RL
    Virol J; 2021 Sep; 18(1):192. PubMed ID: 34556128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaginal Self-Sampling for Human Papillomavirus Infection as a Primary Cervical Cancer Screening Tool in a Haitian Population.
    Boggan JC; Walmer DK; Henderson G; Chakhtoura N; McCarthy SH; Beauvais HJ; Smith JS
    Sex Transm Dis; 2015 Nov; 42(11):655-9. PubMed ID: 26462192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPV detection and measurement of HPV-16, telomerase, and survivin transcripts in colposcopy clinic patients.
    Lanham S; Herbert A; Watt P
    J Clin Pathol; 2001 Apr; 54(4):304-8. PubMed ID: 11304848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of HPV 16 PCR detection in self- compared with clinician-collected samples in women referred for colposcopy.
    Daponte A; Pournaras S; Mademtzis I; Hadjichristodoulou C; Kostopoulou E; Maniatis AN; Messinis IE
    Gynecol Oncol; 2006 Nov; 103(2):463-6. PubMed ID: 16626791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of human papillomavirus detection by Aptima HPV and cobas HPV tests in a population of women referred for colposcopy following detection of atypical squamous cells of undetermined significance by Pap cytology.
    Castle PE; Eaton B; Reid J; Getman D; Dockter J
    J Clin Microbiol; 2015 Apr; 53(4):1277-81. PubMed ID: 25653409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer.
    Ratnam S; Coutlee F; Fontaine D; Bentley J; Escott N; Ghatage P; Gadag V; Holloway G; Bartellas E; Kum N; Giede C; Lear A
    J Clin Microbiol; 2011 Feb; 49(2):557-64. PubMed ID: 21147950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consistency in human papillomavirus type detection between self-collected vaginal specimens and physician-sampled cervical specimens.
    Chou HH; Yang CY; Chao A; Lin H; Lu CH; Ou YC; Hsu ST; Shih YH; Huang HJ; Lin CT; Chen MY; Sun L; Tsai CC; Fu HC; Huang KG; Wu KY; Wu CH; Hsieh WC; Huang YT; Chen LH; Yang LY; Chang WY; Chang TC; Lai CH
    J Med Virol; 2024 Mar; 96(3):e29426. PubMed ID: 38420851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of first-void urine with Aptima Transfer Solution increases detection of high-risk HPV E6/E7 mRNA.
    Arias M; Jang D; Dockter J; Ratnam S; Shah A; Elit L; Smieja M; Lytwyn A; Getman D; Weinbaum B; Chernesky M
    J Virol Methods; 2019 May; 267():48-52. PubMed ID: 30797768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dry self-sampling versus provider-sampling of cervicovaginal specimens for human papillomavirus detection in the Inuit population of Nunavik, Quebec.
    Cerigo H; Coutlée F; Franco EL; Brassard P
    J Med Screen; 2012 Mar; 19(1):42-8. PubMed ID: 22438506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of different human papillomavirus tests in PreservCyt versus SurePath in a referral population-PREDICTORS 4.
    Cuzick J; Ahmad AS; Austin J; Cadman L; Ho L; Terry G; Kleeman M; Ashdown-Barr L; Lyons D; Stoler M; Szarewski A
    J Clin Virol; 2016 Sep; 82():145-151. PubMed ID: 27498250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.